WTX-124, a Conditionally Activated Wild-Type IL2, Maximizes the Therapeutic Index of IL2, Unlike "Non-Alpha" Muteins.
Saved in:
| Title: | WTX-124, a Conditionally Activated Wild-Type IL2, Maximizes the Therapeutic Index of IL2, Unlike "Non-Alpha" Muteins. |
|---|---|
| Authors: | Nirschl CJ; Werewolf Therapeutics Inc., Watertown, Massachusetts., Subramanian KK; Werewolf Therapeutics Inc., Watertown, Massachusetts., Brodkin HR; Werewolf Therapeutics Inc., Watertown, Massachusetts., Domonkos C; Werewolf Therapeutics Inc., Watertown, Massachusetts., Dwyer CJ; Werewolf Therapeutics Inc., Watertown, Massachusetts., Hicklin DJ; Werewolf Therapeutics Inc., Watertown, Massachusetts., Isaacs R; Werewolf Therapeutics Inc., Watertown, Massachusetts., Ismail NS; Werewolf Therapeutics Inc., Watertown, Massachusetts., LePrevost J; Werewolf Therapeutics Inc., Watertown, Massachusetts., Lewis Y; Werewolf Therapeutics Inc., Watertown, Massachusetts., Morris K; Werewolf Therapeutics Inc., Watertown, Massachusetts., Seidel-Dugan C; Werewolf Therapeutics Inc., Watertown, Massachusetts., Steuert Z; Werewolf Therapeutics Inc., Watertown, Massachusetts., Sullivan JM; Werewolf Therapeutics Inc., Watertown, Massachusetts., Chopra SS; Werewolf Therapeutics Inc., Watertown, Massachusetts., Salmeron A; Werewolf Therapeutics Inc., Watertown, Massachusetts., Winston WM; Werewolf Therapeutics Inc., Watertown, Massachusetts. |
| Source: | Cancer immunology research [Cancer Immunol Res] 2026 Mar 04; Vol. 14 (3), pp. 434-449. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
